Pediatric specialists at Children’s Hospital of New York at NewYork-Presbyterian are among the most experienced in the nation, providing children and adolescents with access to innovative treatments and unmatched clinical expertise. In 2025, experts from Columbia and Weill Cornell Medicine performed milestone surgeries to treat rare and life-threatening diseases; published research to provide clinical insights into conditions ranging from severe aplastic anemia to adolescent depression; leveraged genomics and gene therapy to address congenital disorders, and more. Our specialists are devoted to pushing the boundaries of medicine to ensure children receive the most advanced care and the best possible outcomes.
At the Children's Hospital of New York, our pediatric cardiologists, interventional cardiologists, and cardiovascular surgeons from Columbia and Weill Cornell Medicine collaborate seamlessly to manage every form of heart disease in infants and children. Our teams work tirelessly to provide treatments for the most complex heart diseases with the latest imaging technologies, medical therapies, and surgical, transcatheter and hybrid procedures.
Pediatric Cardiology (Heart)
Featured Updates
On this episode of Advances in Care, Erin Welsh is joined by Dr. Lawrence Lustig, chair of the Department of Otolaryngology – Head & Neck Surgery at NewYork-Presbyterian and Columbia. Dr. Lustig has spent decades working to advance various interventions to treat genetic hearing loss and after years of research his team was the first to show that gene therapies could be effective at reversing genetic hearing loss in mouse models and eventually, humans. In April 2026, the FDA approved the first ever gene therapy for genetic deafness based on the work pushed forward by Dr. Lustig.










